Cyriax Capsular Stretching Technique and Mulligan Mobilization in Adhesive Capsulitis

May 15, 2026 updated by: Elite College of Management Sciences, Gujranwala, Pakistan

Comparative Effects of Cyrixa Capsular Stretching Technique Versus Mulligan Mobilization in Adhesive Capsulitis

This study aims to evaluate the comparative effectiveness of Mulligan's mobilization versus the Cyriax capsular stretching technique for individuals suffering from adhesive capsulitis. Specifically, the research focuses on determining which approach is more successful in alleviating pain, improving shoulder range of motion (ROM), and reducing functional disability.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This randomized clinical trial, conducted in Gujranwala, involved 30 participants with adhesive capsulitis who were assigned via a lottery method into two equal groups: one receiving Cyriax capsular stretching and the other Mulligan's mobilization. Both cohorts underwent a standard baseline regimen of moist heat, TENS, and therapeutic exercises over a four-week period.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab Province
      • Gujranwala, Punjab Province, Pakistan
        • Elite College of Management Sciences, Gujranwala

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • individuals with age thirty to sixty five years
  • individuals with more than three months old frozen shoulder

Exclusion Criteria:

  • arthritis of shoulder
  • trauma
  • surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cyriax Technique
along with Baseline treatment, cyriax capsular stretching is given to group 1 with 3 sets of 8-10 reps.
Other: Cyriax Technique
along with Baseline Electrotherapeutic treatment, Cyriax Stretching Technique is given to group 1 with 3 sets of 8-10 reps.
Active Comparator: Mulligan Mobilization
along with Baseline treatment, Mulligan mobilization is given to group 1 with 3 sets of 8-10 reps.
Other: Mulligan Mobilization
along with Baseline Electrotherapeutic treatment, Mulligan Mobilization is given to group 1 with 3 sets of 8-10 reps.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric pain rating scale
Time Frame: 4 weeks
it is used to measure pain and a has a scale of 0-10 where 0 means no pain and 10 means worst possible pain
4 weeks
Shoulder pain and disability index
Time Frame: 4 weeks
it is used to measure the impact of shoulder pathology on a patient's life. A higher score indicates greater pain and functional impairment. A score of 0% represents no disability, while 100% represents maximum disability.
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: 4 weeks
Goniometer is used to measure improvement in shoulder range of motion
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Elite College of Management Sciences, Gujranwala, Pakistan

Investigators

  • Study Director: Imran Rafiq, PhD Rehabilitation Sciences, Elite College of Management Sciences, Gujranwala

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 27, 2025

Primary Completion (Actual)

April 10, 2026

Study Completion (Actual)

April 30, 2026

Study Registration Dates

First Submitted

May 15, 2026

First Submitted That Met QC Criteria

May 15, 2026

First Posted (Actual)

May 22, 2026

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 15, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021-066492

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adhesive Capsulitis

Clinical Trials on Cyriax Technique

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe